Bluestar Adisseo Company (SHA:600299)

Market Cap	31.17B +16.1%
Revenue (ttm)	17.33B +6.1%
Net Income	995.25M -28.5%
EPS	0.36 -31.0%
Shares Out	3.08B
PE Ratio	28.14
Forward PE	9.31
Dividend	0.15 (1.49%)
Ex-Dividend Date	Feb 27, 2026

Volume	12,385,718
Open	10.27
Previous Close	10.12
Day's Range	9.93 - 10.27
52-Week Range	8.66 - 16.48
Beta	0.30
Analysts	Strong Buy
Price Target	17.35 (+72.81%)
Earnings Date	Aug 28, 2026

About Bluestar Adisseo Company

Bluestar Adisseo Company, together with its subsidiaries, engages in the research, development, production, and sale of poultry, ruminant, swine, and aquaculture nutrition additives. The company also offers mycotoxin management and palatability comprising, Unike Plus, Unike, Oxy-Nil, Mold-Nil, Salmo-Nil, Toxy-Nil, Krave AP, Optisweet, Gusti Plus, Maxarome, Delistart, Pepsea, Nutri-Bind Aqua, and Oxy-Nil Aqua Zero; enzymes and emulsifiers, including Rhodimet AT88 and Rhodimet; antioxidants and health by nutrition products, comprising Rhodimet AT...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1939
• Employees: 3,295
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600299

Financial Performance

In 2025, Bluestar Adisseo Company's revenue was 17.23 billion, an increase of 10.92% compared to the previous year's 15.53 billion. Earnings were 1.15 billion, a decrease of -4.13%.

Analyst Summary

According to 2 analysts, the average rating for 600299 stock is "Strong Buy." The 12-month stock price target is ¥17.35, which is an increase of 72.81% from the latest price.

Price Target

¥17.35

(72.81% upside)

Analyst Consensus: Strong Buy